Impact Partnership Wealth’s ResMed RMD Stock Holding History

Impact Partnership Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,116	Closed	-$1.23M	–	434
2025 Q4	$1.23M	Buy	5,116 +2,436	+91%	+$623K	0.16%	89
2025 Q3	$734K	Buy	+2,680	New	+$732K	0.11%	124
2025 Q2	–	Sell	-2,403	Closed	-$538K	–	346
2025 Q1	$538K	Buy	2,403 +195	+9%	+$45.5K	0.11%	101
2024 Q4	$505K	Buy	+2,208	New	+$532K	0.1%	124

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Impact Partnership Wealth's RMD Position: Q1 2026 in Review

Impact Partnership Wealth sold out of ResMed (RMD) in Q1 2026, closing a stake of 5,116 shares — an estimated $1.23M sold.

Impact Partnership Wealth first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $1.23M in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Impact Partnership Wealth reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Impact Partnership Wealth sold 5,116 ResMed shares in Q1 2026, an estimated $1.23M.
Impact Partnership Wealth first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
Impact Partnership Wealth's ResMed position peaked at $1.23M in Q4 2025.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.